Model
Edge
Five Prime Therapeutics, Inc.
0001518724
Filing type
4
Filing date
Jun 11, 2019
Updated
Jun 12, 2019 ยท 12:15 PM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership